Accuneb and Aspirin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Accuneb (albuterol sulfate) and Aspirin (aspirin). Common drug interactions include cardiac failure acute among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Accuneb and Aspirin. It is created by eHealthMe based on reports of 47 people who take the same drugs from the FDA, and is updated regularly.

What is Accuneb?

Accuneb has active ingredients of albuterol sulfate. eHealthMe is studying from 189 Accuneb users. Check the latest studies of Accuneb.

What is Aspirin?

Aspirin has active ingredients of aspirin. It is often used in blood clots. eHealthMe is studying from 632,088 Aspirin users. Check the latest studies of Aspirin.



On Jul, 26, 2026

47 people who take Accuneb and Aspirin together, and have interactions are studied.

Accuneb and Aspirin drug interactions.

What are the common drug interactions of Accuneb and Aspirin, by gender? *:

female:

  1. Cardiac failure acute
  2. Cardiac failure congestive
  3. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  4. Cough
  5. Cyst (a closed sac)
  6. Death
  7. Dyspnoea (difficult or laboured respiration)
  8. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Mobility decreased (ability to move is reduced)

male:

  1. Anxiety
  2. Arthralgia (joint pain)
  3. Metastases to bone (cancer spreads to bone)
  4. Muscular weakness (muscle weakness)
  5. Pain
  6. Radiculitis lumbosacral (inflammation of nerve root at labosacral vertebrea)
  7. Spinal column stenosis (narrowing of spinal column)
  8. Spinal osteoarthritis (joint cartilage loss in spine)
  9. Tendon disorder (disease of tendon)
  10. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)

What are the common drug interactions of Accuneb and Aspirin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Cardiac arrest
  2. Dyspnoea (difficult or laboured respiration)
  3. Respiratory distress (difficulty in breathing)
  4. Respiratory failure (inadequate gas exchange by the respiratory system)

20-29:

n/a

30-39:

  1. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  2. Sleep disorder
  3. Urticaria (rash of round, red welts on the skin that itch intensely)

40-49:

  1. Flushing (the warm, red condition of human skin)
  2. Hospitalisation
  3. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

50-59:

  1. Dermal cyst
  2. Diabetes mellitus inadequate control
  3. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  4. Fatigue (feeling of tiredness)
  5. Gastrointestinal bacterial infection (infection of the stomach and intestines caused by bacteria)
  6. Headache (pain in head)
  7. Hypoacusis (loss of hearing)
  8. Immune system disorder
  9. Lower respiratory tract infection viral
  10. Mobility decreased (ability to move is reduced)

60+:

  1. Anxiety
  2. Bone density decreased
  3. Joint effusion (presence of extra fluid in joint covering)
  4. Metastases to bone (cancer spreads to bone)
  5. Muscular weakness (muscle weakness)
  6. Radiculitis lumbosacral (inflammation of nerve root at labosacral vertebrea)
  7. Spinal column stenosis (narrowing of spinal column)
  8. Spinal osteoarthritis (joint cartilage loss in spine)
  9. Tendon disorder (disease of tendon)
  10. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)

What are the existing conditions these people have? *

  1. Wheezing (a high-pitched whistling sound made while you breath): 11 people, 23.40%
  2. Sleep Disorder: 8 people, 17.02%
  3. Pain: 8 people, 17.02%
  4. Metastases To Bone (cancer spreads to bone): 8 people, 17.02%
  5. Cough: 6 people, 12.77%
  6. Muscle Spasms (muscle contraction): 5 people, 10.64%
  7. Constipation: 4 people, 8.51%
  8. Dyspnea (difficult or laboured breathing): 4 people, 8.51%
  9. High Blood Pressure: 4 people, 8.51%
  10. Insomnia (sleeplessness): 3 people, 6.38%

* Approximation only. Some reports may have incomplete information.

Do you take Accuneb and Aspirin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Accuneb and Aspirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Accuneb:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Aspirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Accuneb and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aspirin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate and aspirin (the active ingredients of Accuneb and Aspirin, respectively), and Accuneb and Aspirin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: